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Summary. The effects of NG-nitro-L-arginine methyl es- 
ter (L-NAME), an inhibitor of the endothelial nitric ox- 
ide (NO) biosynthesis, on systemic and pulmonary 
haemodynamics, and tissue as well as arteriovenous anas- 
tomotic blood flows were investigated in the anaesthet- 
ized pig, using simultaneous injections of radioactive 
microspheres of two different sizes (diameter: 15 and 
50~tm). L-NAME (1, 3 and 10mg'kg -1) reduced sys- 
temic and pulmonary artery conductance and cardiac 
output, but heart rate and mean arterial blood pressure 
remained unchanged. L-arginine reversed the systemic 
and pulmonary haemodynamic changes induced by L- 
NAME. As detected with 15 gm microspheres, L-NAME 
(1 and 3 mg'kg -1) decreased tissue blood flow to and 
vascular conductance in the eyes, lungs, atria, kidneys, 
adrenals and liver. Furthermore, the difference between 
blood flows simultaneously measured with 15 and 50 gm 
microspheres, which can be equated to blood flow 
through arteriovenous anastomoses with a diameter be- 
tween about 28 and 90 gm, was reduced by L-NAME 
(3 mg. kg-1) in the skin of head and gluteal regions and, 
as indicated by the microsphere content of the lungs, in 
the total systemic irculation. These results suggest hat 
in the anaesthetized pig (i) NO is involved in the regula- 
tion of both systemic and pulmonary vascular conduc- 
tance, (ii) the decrease in systemic vascular conductance 
is in part due to constriction of systemic arteriovenous 
anastomoses, and (iii) the decrease in pulmonary vascular 
conductance, leading to reduction of cardiac output, 
seems to negate the expected rise in arterial blood pres- 
sure observed, for example, in rats and rabbits following 
inhibition of NO-synthesis. 
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Introduction 
Vascular smooth muscle tone is regulated by the release 
of endothelium-derived r laxing factor (EDRF), which 
has now been identified as nitric oxide (NO) (Ignarro et 
al. 1987; Palmer et al. 1987) or a related nitrosothiol (My- 
ers et al. 1990). Its synthesis from the precursor L- 
arginine is mediated by the enzyme NO-synthase present 
in endothelial cells (Palmer et al. 1988; F6rstermann etal. 
1991). Analogues of L-arginine, including NG-nitro-L - 
arginine (L-NNA) and its methyl ester (L-NAME), have 
been shown to inhibit NO biosynthesis (Mtilsch and 
Busse 1990; Rees et al. 1990). These NO-synthase in- 
hibitors induce a sustained rise in arterial blood pressure 
in rats (Gardiner et al. 1990; Rees et al. 1990; Van 
Gelderen et al. 1991) and rabbits (Humphries et al. 1991; 
Duet  al. 1992), indicating a basal NO release mediating 
vasodilatation. In these species, blood pressure levation 
is usually accompanied by a reflex bradycardia. Less pro- 
nounced effects on blood pressure as well as heart rate 
were found with NO-synthase inhibitors in lambs 
(Fineman et al. 1991), goats (Garcia et al. 1992), clogs 
(Richard et al. 1991; Klabunde t al. 1991) and cats (Van 
Gelderen et al. 1991; McMahon et al. 1992); in cats, 
microsphere content of the lungs, used as an index for 
systemic arteriovenous hunting, was decreased (Van 
Gelderen et al. 1991). The reason for the poor pressor e- 
sponse following inhibition of NO synthesis in these ani- 
mal species is not known, but it is possible that the 
pressor response due to rise in systemic vascular esis- 
tance is offset by an additional decrease in cardiac output 
as a consequence of a more marked increase in pulmo- 
nary vascular esistance. Indeed, NO-synthesis inhibitors 
have been shown to block pulmonary vasodilator e- 
sponse to vagal stimulation in cats (McMahon et al. 
1992), attenuate endothelium-dependent pulmonary 
vasodilatation, leading to pulmonary hypertension, in 
lambs (Fineman et al. 1991), and to produce pulmonary 
hypertension and reduced cardiac output in dogs 
(Klabunde t al. 1991). The purpose of this investigation 
was to evaluate the effects of L-NAME on systemic and 
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pu lmonary  haemodynamics ,  t issue b lood  f lows and  tota l  
and  reg iona l  a r te r iovenous  hunt ing ,  us ing  rad ioact ive  
microsphere  o f  two d i f ferent  d iameters  (15 and  50 ~tm) in 
anaesthet i zed  pigs. P re l iminary  f ind ings  have been re- 
por ted  e lsewhere (Van Ge lderen  et al. 1992). 
Methods 
General Twelve male and female pigs (weight 17.8+0.3kg) were 
anaesthetized with metomidate (120 mg, i.v.) following sedation with 
azaperone (150 mg, i.m.). After intubation, the animals were connected 
to a respirator (Bear 2E, BeMeds AG, Baar, Switzerland) for ventilation 
with a mixture of oxygen and room air. Arterial blood gases were mea- 
sured (ABL-2, Radiometer, Copenhagen, Denmark) and kept within a 
physiological range (pH 7.45-7.55, PO 2 90-120mmHg, PCO 2 
35-  45 mmHg) by adjusting the ventilation rate and the oxygen-content 
of the mixture. Anaesthesia was maintained by infusing pentobarbitone 
sodium in the right femoral vein; 20mg.kg- l .h  -1 during the first 
hour followed by 12 mg.kg- l .h  -1. A catheter was introduced in the 
left femoral artery for blood pressure measurement. Cardiac output was 
measured with the help of a 6F-Swan-Ganz thermodilution catheter 
(Corodyn, Braun Melsungen AG, Melsungen, Germany), which was ad- 
vanced into the pulmonary artery via the left femoral vein and connect- 
ed to a cardiac output computer (WTI, Rotterdam, The Netherlands). 
Another catheter was placed in the left ventricle via the left common 
carotid artery to inject radioactive microspheres. To calibrate the 
radioactive microsphere method, arterial reference samples were collect- 
ed from the aorta via a catheter in the right femoral artery. Blood pres- 
sures were continuously measured in the aorta, the pulmonary artery 
and the left ventricle, using pressure transducers (Statham P23, Hato 
Rey, Puerto Rico). Mean arterial blood pressure was calculated as the 
sum of the diastolic pressure and one third of the difference between 
systolic and diastolic pressure. Heart rate, left ventricular end diastolic 
pressure and the peak rate of rise in left ventricular pressure (LV dP/dt) 
were derived from the ventricular pulse pressure signal. Pulmonary cap- 
illary wedge pressure was measured by inflating the Swan-Ganz-balloon 
and pulmonary artery resistance was calculated by dividing the differ- 
ence between mean pulmonary artery and capillary wedge pressures by 
cardiac output. In some experiments he last measurement (after L- 
arginine) of pulmonary capillary wedge pressure could not be measured 
and, therefore, pulmonary vascular resistance was not calculated. Drugs 
were injected into the aorta to prevent high concentrations of drugs 
reaching the heart. All catheters were filled with a heparin sodium solu- 
tion (80IU'm1-1) to prevent clotting. Body temperature was kept 
above 37 °C and physiological saline was infused to compensate for flu- 
id loss. The animals were allowed to stabilize for at least 45 min before 
the experiment s arted. 
Radioactive mierosphere t chnique. The regional distribution of the 
cardiac output was determined with the radioactive microsphere t ch- 
nique using the reference blood sample method (Heymann et al. 1977), 
modified for use of simultaneous injection of microspheres of different 
diameter (see Saxena nd Verdouw 1985; Den Boer et al. 1992a, b). The 
microspheres u ed in this investigation were of 15 and 50 ~tm diameter 
and labelled with either 141Ce (15 Ixm), ll3Sn (50 rtm), l°3Ru (50 jxm), 
95Nb (I5 [xm) or 468c (15 gm) (NEN Company, Dreiech, Germany). 
The order of 15 and 50 ~tm spheres injected before and after the drugs 
was randomized. The approximate number of microspheres given per 
isotope was about 1000000 for 15 gm and 50000 for 50p~m. The 
microspheres were vortexed for about 30 s and then injected into the left 
ventricle against the direction of the flood blow to ensure uniform mix- 
ing. An arterial reference sample was withdrawn (rat: 10.5 ml'min -1) 
using a pump (Braun-Mclsungen, Melsungen, Germany), starting about 
15 s before and continuing until 1 min after the injection of the 
microspheres. At the end of the experiment the animals were killed by 
an overdose of sodium pentobarbitone and the different issues were 
dissected out, weighed and put in vials. The radioactivity in these vials 
and in the blood samples was counted for 5 - 10 rain in a gamma-scintil- 
lation counter (Packard, Minaxi Autogamma 5000) using suitable win- 
dows for discriminating the different isotopes. For each tissue, blood 
flow (Qtis) was calculated using the formula: Qtis = (Itis/I~,f) × 10.5, in 
which Iri s and Ire f represent, respectively, radioactivity in the tissue and 
in the reference blood sample. Tissue vascular conductance was calcu- 
lated by dividing the tissue blood flow value by mean arterial blood 
pressure. Tissue blood flow and conductance values have been expressed 
per 100 g of tissue. All data were processed by a personal computer 
(Olivetti PCS 286) using a set of specially developed computer pro- 
grams, based on those described earlier (Saxena et al. 1980). 
As extensively discussed elsewhere (Johnston and Saxena 1978; Sax- 
ena and Verdouw 1985; Den Boer et al. 1992a, b), not all microspheres 
are trapped in tissues; they escape ntrapment via arteriovenous anasto- 
moses to appear into the venous blood and are ultimately sieved in the 
lungs. Lung radioactivity, therefore, represents for the greatest part 
arteriovenous anastomotic blood flow, although a small part (1 - 1.5% 
of cardiac output) is derived from the bronchial arteries (Ballle et al. 
1982; Wu et al. 1988). Based on the demonstration in the hamster cheek 
pouch that microspheres of 15 and 24 ~tm diameter are already trapped 
in blood vessels with a diameter of 27.7 and 42.7 ~tm, respectively 
(Dickhoner et al. 1978), it may be assumed that 15 ~tm spheres detected 
in a certain tissue reflect blood flow through vessels with a diameter 
smaller than about 28 Ixm (capillaries and small arteriovenous anasto- 
moses), whereas 50 ~tm spheres reflect blood flow through vessels under 
90 ~m diameter (capillaries and medium-sized arteriovenous anasto- 
moses). Therefore, the difference between blood flow values simulta- 
neously obtained with 15 and 50 ~tm microspheres may serve as an index 
of the blood flow in arteriovenous anastomoses with a diameter be- 
tween 28 and 90 ~tm. 
Experimental protocol At baseline values of systemic and pulmonary 
haemodynamic variables were collated and a mixture of 15 and 50 Ixm 
microspheres was injected in the left ventricle to determine baseline re- 
gional tissue blood flows. The animals were then divided at random into 
two groups (n = 6 each), which were treated every 25 min with three 
consecutive doses of L-NAME (1, 3 and 10 mg.kg -1) or saline (3 ml 
each). Systemic and pulmonary haemodynamic values were collected 
after each dose of L-NAME or saline. After the first dose 15 Ixm 
microspheres were injected, whereas after the second ose 15 and 50 Ixm 
spheres were injected simultaneously. Finally, in both groups five 
animals were treated with L-arginine (1000 mg.kg -I) and, 15 rain later, 
the haemodynamic variables, except pulmonary capillary wedge pres- 
sure, were collated again. 
Data presentation a d analysis. All data in the text are mentioned as 
mean + SEM. The effects of treatments were analyzed in each group us- 
ing a repeated measurements analysis of variance with the factors size 
and treatment. Once the samples represented different populations, the 
values after the different reatments were compared to baseline values 
by use of Duncan's new multiple range test. In each group the difference 
in blood flow values obtained with 15 and 50 ~tm microspheres before 
and after treatment were analyzed with a Student's t-test for paired da- 
ta. The changes among the two groups were tested by a Student's t-test. 
Statistical significance was accepted at P<0.05 (two-tailed). 
Drugs. The drugs used in this study were: azaperone, metomidate (both 
from Janssen Pharmaceutica, Beerse, Belgium), L-arginine, N ~- 
nitro-L-arginine methyl ester (both from Sigma, St. Louis, Mo., USA), 
pentobarbitone sodium (Narcovet, Apharmo, Arnhem, The Nether- 
lands) and heparin sodium (Thromboliquine, Organon Teknika B.V., 
Boxtel, The Netherlands). All doses refer to the respective salts. 
Results 
Systemic and pulmonary haemodynamics 
Systemic  and  pu lmonary  haemodynamic  var iab les  in the  
two groups  at  base l ine  and  fo l lowing t reatment  w i th  L- 
NAME or  sa l ine are dep ic ted  in Fig. 1. Apar t  f rom mean 
ar ter ia l  b lood  pressure,  wh ich  was somewhat  h igher  in 
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Fig. 1. Systemic haemodynamics n anaesthetized pigs 
before (BL) and after saline (open circles) or L- 
NAME (closed circles), followed in both groups 
(n = 6 each) by L-arginine (i000 mg.kg-I; ARG). The 
haemodynamic variables are abbreviated: heart rate 
(HR), mean arterial blood pressure (MBP), cardiac 
output (CO), stroke volume (SV), mean pulmonary 
artery pressure (MPAP), left ventricular end diastolic 
pressure (LVEDP), systemic vascular conductance 
(SVC) and pulmonary artery conductance (PVC). All 
values are shown as mean+SEM, but in some cases 
error bars fall within the limits of the symbol. 
*P<0.05 vs. corresponding saline value; §P<0.05 vs. 
baseline value, in case of ARG only 
the saline group, no differences were observed initially be- 
tween the groups. L-NAME significantly reduced cardiac 
output (by 40_+2 and 45_+4°7o after 3 and 10mg.kg -~, 
respectively) and stroke volume (by 28+_3, 46+5 and 
53_+5% after the three doses, respectively), but did not 
significantly affect heart rate, mean arterial blood pres- 
sure, LV dP/dt or pulmonary capillary wedge pressure 
(both not shown in Fig. 1). Left venticular end diastolic 
pressure decreased significantly after 3mg'kg -~ L- 
NAME (-17-+8%), whereas mean pulmonary artery 
pressure increased significantly after the two highest dos- 
es (51 _+ 11 and 62+_ 11%, respectively). L-NAME signifi- 
cantly reduced systemic (by 30_+3, 36_+6 and 28_+11°70 
after the three doses, respectively) and pulmonary (by 
65 +_ 5 and 65 + 2% after 3 and 10 rag" kg- l, respectively) 
vascular conductances (Fig. 1). 
Except for arterial blood pressure, administration of 
L-arginine (1000 mg. kg -~) partially or fully reversed the 
systemic and pulmonary haemodynamic changes induced 
by L-NAME. 
Tissue blood flow and vascular conductance 
Tissue blood flows measured with 15 ~tm radioactive 
microspheres atbaseline and after L-NAME are shown in 
Fig. 2. L-NAME, 1 and 3mg.kg -1, respectively, de- 
creased blood flow to the eyes (42-+5 and 62_+4o70), atria 
(37+8 and 44_+9%), lungs (42+8 and 68_+5o70), kidneys 
(31+2 and 51 +4%), and adrenals (35+7 and 60_+707o). 
When compared to baseline values, blood flow was re- 
duced in the bones (32-+5 and 39_+6°7o) and liver (32_+ 12, 
1 mg.kg -I only). L-NAME induced no significant 
change in blood flow to the brain as well as to the skin, 
tongue, spleen, stomach, mesentery, intestines or skeletal 
muscles (not shown in Fig. 2). 
Since mean arterial blood pressure changed only 
moderately during the course of the experiment, similar 
changes were observed in tissue vascular conductances. 
The vascular conductance was decreased in the adrenals 
(37+7 and 59+5o70), eyes (45___5 and 60+4o70), kidneys 
(35+4 and 48+4o70), bones (36_+5 and 35_+8°7o) and 
lungs (46-+7 and 67-+5°7o) by L-NAME (1 and 
3 mg. kg-1, respectively). Additionally, the lower dose of 
L-NAME also reduced vascular conductance in the liver 
(35 +_ 12 %) and heart (16 -+ 5 o70). In the heart, the effect of 
L-NAME was not observed in the ventricles and was con- 
fined to the atria, where vascular conductance was 
decreased by 42+6 and 44_+6% by 1 and 3 mg'kg -1 of 
L-NAME, respectively. 
Total systemic and regional arteriovenous 
anastomotic blood flow 
The presence of a substantial number of 15 and 50 ~tm 
microspheres, with the latter in preponderance, in the 
lungs demonstrated that abundant systemic arterio- 
venous shunting occurs in anaesthetized pigs (Table 1; 
Fig. 3). L-NAME (3 mg. kg-1) clearly reduced the num- 
ber of both 15 and 50 ~tm microspheres a well as the dif- 
ference between these two spheres (62_+ 6%0), indicating a 
decrease in total systemic shunting through arteriovenous 
anastomoses between 28 and 90 ~tm diameter (Fig. 3). At 
the tissue level, similar blood flow values were found with 
the two sizes of microspheres in all tissues dissected, ex- 
cept in the skin and tongue (Table 1). The difference in 
the blood flows measured with 15 and 50~tm 
microspheres in the skin and tongue reflects the presence 
of arteriovenous anastomoses in these tissues. Adminis- 
tration of L-NAME (3 mg.kg -1) significantly reduced 
this difference in the skin (by 75_+5o70), but not in the 
tongue (Fig. 3). 
It may be noted that skin obtained from different re- 
gions showed heterogeneity (Fig. 4). Thus, the head and 
gluteal skin exhibited a large difference between 15 and 
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Fig. 2. Tissue blood flows measured with 15 ~tm radioactive micro- 
spheres in pigs treated with either saline (upper panels," n = 6) or L- 
NAME (lower panels; n = 6). In each set of panels, baseline blood flow 
is shown by the open bars, whereas increasing doses of L-NAME (1 and 
3 mg" kg-1) or saline are represented by the hatched and cross hatched 
bars, respectively. Values are shown as mean+SEM, a, P<0.05 vs 
baseline only; b, P<0.05 vs saline experiments 
]Fig. 3. The effect of saline (n = 6) or L-NAME (3 mg.kg-1; n = 6) on 
total systemic (lung) and regional arteriovenous anastomoses blood 
flow, represented by the difference in blood flow measured with 15 gm 
(open bars) and 50 ~tm (cross-hatched bars) radioactive microspheres. 
In each set of panels the absolute difference is depicted by the hatched 
bar. Values are given as mean_+ SEM. a, Denotes ignificant difference 
between 15 p.m and 50gin; b, denotes significant difference from 
baseline (P< 0.05); c, denotes ignificant change in difference betwen 15 
and 50 ram (P<0.05) 
50 gm microsphere blood flow values, while those from 
the abdominal and back region did not. The blood flow 
differences in were significantly decreased by L-NAME 
(3 mg'kg -1) in the gluteal and head skin by 70+5% and 
70+4%, respectively (Fig. 4). 
Discussion 
The present investigation was devoted to study the effects 
of NO-synthase inhibition in anaesthetized pigs using L- 
NAME. Recently, Buxton and coworkers reported that 
several alkyl esters of L-arginine analogues, including L- 
NAME, have atropine-like properties in both radioligand 
binding and functional in vitro studies. However, 
muscarinic holinergic blockade is not likely to play a 
meaningful role in our studies. Firstly, in vivo L-NAME 
is rapidly dealkylated into L-NNA, which seems to be re- 
sponsible for the pharmacological actions in intact ani- 
mals (Schwarzacher and Raberger 1992), but is devoid of 
antimuscarinic property (Buxton et al. 1993). Secondly, 
in our previous tudies in both rats and cats, L-NAME 
(up to 30 mg-kg-l) failed to attenuate he magnitude of 
hypotensive r sponses to acetylcholine (Van Gelderen et 
al. 1991). Lastly, the effects of L-NAME in the present 
study were partly reversed by L-arginine, which does not 
affect he antimuscarinic a tion of L-NAME (Buxton et 
al. 1993). 
Systemic and pulmonary haemodynamics 
Several studies have demonstrated a pronounced increase 
in blood pressure following administration f L-NNA or 
L-NAME to rats (Gardiner et al. 1990; Rees et al. 1990; 
Van Gelderen et al. 1991) and rabbits (Wiklund et al. 
1990); this effect is thought to be due to vasoconstriction 
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Fig. 4. The effect of saline (n = 6) 
or L-NAME (3 mg.kg-1 ;  n = 6) on 
arteriovenous anastomoses blood 
flow in several skin regions, repre- 
sented by the difference in blood 
flow measured with 15 I~m (open 
bars) and 50 gm (cross-hatched 
bars) radioactive microspheres. In
each set of panels the absolute dif- 
ference is depicted by the hatched 
bar. Values are given as 
mean_+SEM, a, Denotes significant 
difference between 15 and 50 gm; n, 
denotes ignificant difference from 
baseline (P<0.05); c, denotes ig- 
nificant change in difference be- 
tween 15 and 50 gm (P<0.05) 
resulting from attenuation of basal NO-release. In con- 
trast, the pressor esponses are often quite moderate or 
even absent in dogs, goats, lambs and cats (Fineman et al. 
1991; Klabunde et al. 1991; Van Gelderen et al. 1991; 
Garcia et al. 1992). Similar to our previous observations 
in cats (Van Gelderen et al. 1991), the present experiments 
show that L-NAME did not increase blood pressure in 
anaesthetized pigs, though systemic vascular conduc- 
Table 1. Tissue blood flows (ml. min -  1. i 00 g -  1) at baseline measured 
with 15 ~tm and 50 ~tm radioactive microspheres, aswell as their differ- 
ence (n = 12) 
Tissue Microsphere size Difference 
50-15  Ixm 
15 ~tm 50 ~m 
Lungs* 210+29 90_+15"* -120  _+17 
Brain 39_+ 1.5 41_+ 2.1 2.8+ 1.0 
Eyes 44+ 3.4 48_+ 3.1 4.6_+ 2.0 
Tongue 7_+ 0.4 9_+ 0.6** 1.8_+ 0.4 
Bones 6_+ 0.4 7_+ 0.6 0.6_+ 0.5 
Heart 99_+ 5.6 104_+ 4.5 5.1+ 1.7 
Liver 21_+ 2.8 22_+ 3.2 1.6_+ 0.6 
Spleen 111_+15 119_+17 8.1_+ 3.3 
Stomach 18_+ 1.6 19_+ 1.8 1.0_+ 0.7 
Mesentery 3_+ 0.4 6_+ 1.4 2.5_+ 1.3 
Intestines 39_+ 1.3 40-+ 1.5 1.0_+ 0.8 
Kidneys 220_+ 13 232-+ 14 12 _+ 4.5 
Adrenals 155_+ 15 153 _+20 -2.2_+ 7.2 
Skin 5_+ 0.3 21_+ 2.4** 16 _+ 2.6 
Muscles 5_+ 0.4 5_+ 0.4 0.4_+ 0.2 
* Indicates the sum of total systemic arteriovenous anastomotic and 
bronchial blood flows 
** denotes ignificant difference from the corresponding 15 gm value 
(P<O.05) 
tance was significantly decreased. Coincident with the re- 
duction in systemic vascular conductance, pulmonary 
vascular conductance, l ft ventricular end diastolic pres- 
sure, stroke volume and, ultimately, cardiac output de- 
clined dose-dependently. It is therefore likely that the ex- 
pected rise in arterial blood pressure due to systemic va- 
soconstriction was negated by the fall in cardiac output 
in the pig. A comparable fall in cardiac output has also 
been observed in the anaesthetized dog after the NO-syn- 
thase inhibitors, L-NNA and NC-monomethyl-L-arginine 
(Klabunde t al. 1991; Perrella et al. 1992). 
The reduction of stroke volume and cardiac output is 
best explained by the marked ecrease in pulmonary vas- 
cular conductance, leading to high pulmonary artery 
pressure, though the reduction in systemic vascular con- 
ductance may have partly contributed. Indeed, NO-re- 
lease can be involved in the maintenance of a low vascu- 
lar tone within the pulmonary circulation (Wiklund et al. 
1990; Fineman et al. 1991; Perrella et al. 1991) and exoge- 
nous NO may reverse pulmonary hypertension i man 
(Pepke-Zaba etal. 1991). The rise in mean pulmonary ar- 
tery pressure following L-NAME and the ability of L- 
arginine to reverse the changes induced by L-NAME in 
our experiments are in keeping with this view. 
In conscious rats a direct negative inotropic action of 
L-NAME has been proposed, based upon the reduction 
in stroke volume, LV dP/dtmax and peak aorta blood 
flow (Gardiner et al. 1990). Though N°-methyl-L-argi - 
nine (L-NMA) decreased contactility and cAMP and 
cGMP levels in isoprenaline-stimulated rat perfused 
hearts, the compound failed to reduce LV dP/dtma ~, de- 
spite a decrease in myocardial cGMP content in unstimu- 
lated hearts (Klabunde et al. 1992). In anaesthetized 
dogs, LV dP/dtma x was only slightly decreased by L- 
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NMA (Klabunde t al. 1991), and intracoronary applica- 
tion of L-NAME did not affect myocardial tissue perfu- 
sion measured with radioactive microspheres, though L- 
NAME did induce a local coronary constriction (Richard 
et al. 1991). Similarly, in the present experiments in pigs, 
no evidence for a major negative inotropic effect of L- 
NAME was uncovered as the compound id not lower LV 
dP/dt or ventricular vascular conductance significantly. 
Therefore, a reduction in myocardial oxygen supply due 
to coronary artery constriction by L-NAME is also un- 
likely. 
Tissue blood flow and vascular conductance 
In the anaesthetized pig, L-NAME reduced tissue blood 
flow and vascular conductance in a limited number of tis- 
sues, being most apparent in the adrenals, eyes, kidneys 
and lungs. These findings differ from our previous results 
in cats in which a higher dose (30 mg. kg -1) of L-NAME 
reduced blood flows to abdominal tissues without affect- 
ing renal blood flow (Van Gelderen et al. 1991). Further- 
more, as measured by the radioactive microsphere t ch- 
nique, reduced blood flow was observed in most of the 
tissues in rats following the NO-synthase inhibitor N G- 
monomethyl-L-arginine (Greenblatt et al. 1993). These 
differences may be related to differences in basal NO- 
release between species and tissues or to differences in 
sensitivity of the vascular smooth muscle cells. Thus, iso- 
lated porcine renal and coronary arteries how a similar 
EDRF release but display a difference in sensitivity to the 
released EDRF (Christie and Lewis 1991). In any case, the 
reduced renal conductance following administration f L- 
NAME, an inhibitor of NO-synthase, is in accordance 
with studies in rats (Gardiner et al. 1990; Greenblatt et al. 
1993), rabbits (Humphries et al. 1991) and dogs (Perrella 
et al. 1992), and are indicative of a regulatory role for NO 
in the renal circulation. 
Total systemic and regional arteriovenous shunting 
The use of radioactive microspheres to measure total sys- 
temic (Johnston and Saxena 1978; Saxena et al. 1980; 
Saxena nd Verdouw 1982) and regional (Saxena nd Ver- 
douw 1985; Den Boer et al. 1992a, b) arteriovenous 
anastomotic blood flows has been discussed previously. 
Briefly, microspheres (10 Ixm or larger in diameter) escap- 
ing entrapment in peripheral tissues and sieved by the 
lung capillaries can be used as an index of total systemic 
arteriovenous shunting, whereas the difference between 
tissue blood flows simultaneously measured with micro- 
spheres of different diameters indicates blood flow 
through arteriovenous anastomoses at the tissue level. In 
our case, the difference between blood flows measured 
with 15 and 50 ~tm spheres represents blood flow through 
arteriovenous anastomoses between approximately 28 
and 90 ~tm diameter, as suggested by the relative sizes of 
arterial microvessels and the therein trapped micro- 
spheres (Dickhoner et al. 1978). 
In the present experiments, 21°70 of the 15~tm 
microspheres injected into the heart were detected in the 
lungs. Since bronchial blood flow has been shown to be 
only 1 to 1.5°70 of the cardiac output (Baille et al. 1982; 
Wu et al. 1988), more than 90% of the microspheres 
sieved by the lungs had passed through arteriovenous 
anastomoses. As indicated by the difference between tis- 
sue blood flows measured simultaneously with 15 and 
50 gm spheres, lungs seem to completely sieve micro- 
spheres escaping entrapment mainly in the skin, but also 
in the tongue and, possibly, in some other tissues which 
we did not dissect. Interestingly, skin exhibited regional 
heterogeneity, with the head and gluteal skin having a 
much higher arteriovenous shunting than the skin from 
the abdominal or back region. These results are in agree- 
ment with our previous observations (Saxena and Ver- 
douw 1985; Den Boer et al. 1992b). L-NAME substan- 
tially decreased the total systemic arteriovenous shunting 
as judged by the decrease in the 'lung blood flow' mea- 
sured with 15 ~tm and 50 gm microspheres a well as the 
difference between 'lung blood flow' measured with the 
microspheres of the two sizes. At the tissue level, L- 
NAME significantly decreased the difference between 15 
and 50 gm sphere blood flows and, therefore, shunting in 
medium-sized arteriovenous anastomoses in the head and 
gluteal skin; the apparent lack of effect in abdominal nd 
back skin and tongue may be due to a less pronounced 
shunting in these tissues. 
The effectiveness of L-NAME tempts us to suggest 
that the release of NO from endothelium regulates the 
tone of arteriovenous anastomoses demonstrated in por- 
cine skin. Cutaneous arteriovenous anastomoses are sup- 
posed to have a role in temperature and, perhaps, also in 
blood pressure regulation (Hales and Molyneux 1988); 
NO-release may provide a rapid mechanism to adapt o 
temperature changes. However, at this moment we cannot 
fully exclude that blood flow through arteriovenous 
anastomoses following L-NAME was reduced as a result 
of the fall in cardiac output, causing a diminished blood 
supply to these vessels. 
In conclusion, our results demonstrate that basal NO 
release regulates both systemic and pulmonary conduc- 
tance in the anaesthetized pigs. The expected increase in 
blood pressure due to NO-synthase inhibition is offset by 
the coincident reduction in cardiac output. A part of the 
reduced vascular conductance may be attributed to a con- 
striction of arteriovenous anastomoses. 
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